5 completed, 2 unknown, 1 recruiting, 1 terminated. 3 Not applicable, 2 Phase 3, 2 Phase 4, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 1, Recruiting 1, Unknown 1 |
| Phase 3 | 2 | Completed 2 |
| Phase 4 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Type-2 Diabetes Mellitus: new trials by email Literature Review of Type-2 Diabetes Mellitus trials Research Report on Type-2 Diabetes Mellitus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A U.S. Pilot Human Investigation of RadiofrEquency Vapor Ablation System to Evaluate Safety, TOleRability, and Effectiveness for Proximal Intestinal Mucosal Ablation in Patients With Type 2 Diabetes Mellitus (RESTORE-1 Study) RF Vapor Ablation - Type-2 Diabetes Mellitus | Not applicable | Recruiting | Aqua Medical, Inc. | 20 | 2026-04-01 | 2026-09-22 |
| Stanford Kids CAMP Study Remote Monitoring Program - Pre-diabetes, Obesity | Not applicable | Unknown | Stanford University | 100 | 2022-07-01 | 2022-05-19 |
| Clinical Evaluation of Fenugreek Seed Extract, a Nutraceutical in Patients With Type- 2 Diabetes Oral hypoglycemic agents (pre-specified) [Metformin, Sulfonylurea], Fenugreek Seed extract - Type-2 Diabetes Mellitus | Not applicable | Completed | All India Institute of Medical Sciences, Bhubaneswar | 200 | 2016-01-17 | 2018-08-17 |
| Loop Duodenal Switch Surgery in Morbidly Obese Patients Loop duodenal switch - Obesity, Type-2 Diabetes Mellitus | Terminated | Medical College of Wisconsin | 1 | 2016-01-01 | 2016-07-07 | |
| Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients Ticagrelor + Aspirin, Clopidogrel + Aspirin - Type-2 Diabetes Mellitus, Coronary Artery Disease | Phase 4 | Completed | Juan J Badimon | 20 | 2013-07-01 | 2017-12-08 |
| Early add-on Vildagliptin in Patients With Type 2 Diabetes Inadequately Controlled by Metformin LAF237 (vildagliptin), Metformin - Type-2 Diabetes Mellitus | Phase 4 | Completed | Novartis Pharmaceuticals | 117 | 2013-05-13 | 2017-05-15 |
| Safety and Efficacy Study of Autologous Bone Marrow Aspirate Concentrate for No-Option Critical Limb Ischemia Group A: Intramuscular, Group B: Intraarterial, Group C: Intravenous - Critical Lower Limb Ischemia, Type-2 Diabetes Mellitus | Phase 2 / Phase 3 | Completed | University Hospital Ostrava | 80 | 2012-09-01 | 2021-09-30 |
| Efficacy and Safety of Add-on Therapy With DLBS3233 in Patients With Type-2 Diabetes Mellitus DLBS3233 - Type-2 Diabetes Mellitus | Phase 3 | Completed | Dexa Medica Group | 54 | 2011-09-01 | 2013-05-27 |
| Risk Prediction in Type II Diabetics With Ischemic Heart Disease Type-2 Diabetes Mellitus, Ischemic Heart Disease | Unknown | Thebiosignals.com | 500 | 2010-01-01 | 2014-02-06 |
Diabetes Mellitus (4) · Coronary Artery Disease (2) · Obesity (2) · Glucose Intolerance (1) · Ischemia (1) · Myocardial Ischemia (1) · Pure Autonomic Failure (1) · Thrombosis (1)
Nutritional and Metabolic Diseases (6) · Glucose Metabolism Disorders (5) · Metabolic Diseases (5) · Endocrine System Diseases (4) · Pathological Conditions, Signs and Symptoms (3) · Arterial Occlusive Diseases (2) · Arteriosclerosis (2) · Body Weight (2) · Cardiovascular Diseases (2) · Coronary Disease (2) · Heart Diseases (2) · Nutrition Disorders (2) · Overnutrition (2) · Overweight (2) · Signs and Symptoms (2)
Metformin (2) · 1-(((3-hydroxy-1-adamantyl)amino)acetyl)-2-cyanopyrrolidine (1) · Aspirin (1) · Clopidogrel (1) · DLBS3233 (1) · Hypoglycemic Agents (1) · Sulfonylurea Compounds (1) · Ticagrelor (1) · Vildagliptin (1) · fenugreek seed meal (1)
All India Institute of Medical Sciences, Bhubaneswar (1) · Aqua Medical, Inc. (1) · Dexa Medica Group (1) · Juan J Badimon (1) · Medical College of Wisconsin (1) · Novartis Pharmaceuticals (1) · Stanford University (1) · Thebiosignals.com (1) · University Hospital Ostrava (1)
United States (4) · Czechia (1) · Germany (1) · Hong Kong (1) · India (1) · Indonesia (1)
Askandar Tjokroprawiro, Prof.Dr.dr,SpPD-KEMD,FINASIM (1) · Juan J Badimon, PhD (1) · Karl Sylvester, MD (1) · Nicholas Shaheen, MD (1) · Tammy Kindel, MD (1) · Vaclav Prochazka, MD, PhD, MSc (1)
PMID 11868855, PMID 17313713, PMID 21654091, PMID 24438170, PMID 28837213